Primary Progressive Multiple Sclerosis

Also known as: Multiple Sclerosis (MS) Primary Progressive / Primary Progressive Multiple Sclerosis (PPMS) / Primary Multiple Sclerosis, Progressive / Primary Progressive MS / Multiple Sclerosis, Primary Progressive / Primary-progressive Multiple Sclerosis / Primary progressive multiple sclerosis (disorder)

DrugDrug NameDrug Description
DB11988OcrelizumabA CD20 specific monoclonal antibody used to treat relapsing remitting multiple sclerosis.
DrugDrug NameTargetType
DB11988OcrelizumabB-lymphocyte antigen CD20target
DrugDrug NamePhaseStatusCount
DB19189DPA-714 F-18Not AvailableCompleted1
DB09502Fludeoxyglucose (18F)Not AvailableCompleted1
DB11988OcrelizumabNot AvailableCompleted1
DB00331Metformin0Recruiting1
DB00759Tetracycline0Temporarily Not Available1
DB01076Atorvastatin1Completed1
DB06769Bendamustine1Recruiting1
DB08868Fingolimod1Completed1
DB16170Foralumab1Withdrawn1
DB05259Glatiramer1Completed1
DB00279Liothyronine1Completed1
DB00166Lipoic acid1Completed1
DB00073Rituximab1Completed1
DB00759Tetracycline1Completed1
DB05767Andrographolide1 / 2Unknown Status1
DB00283Clemastine1 / 2Recruiting1
DB09081Idebenone1 / 2Completed2
DB00030Insulin human1 / 2Completed1
DB00455Loratadine1 / 2Recruiting1
DB01285Corticotropin2Terminated1
DB00151Cysteine2Recruiting1
DB08908Dimethyl fumarate2Completed1
DB04573Estriol2Unknown Status1
DB01611Hydroxychloroquine2Completed1
DB05266Ibudilast2Completed1
DB06685Laquinimod2Completed1
DB00331Metformin2Recruiting1
DB00108Natalizumab2Completed1
DB00717Norethisterone2Unknown Status1
DB00316Acetaminophen3Active Not Recruiting1
DB06637Dalfampridine3Completed1
DB00967Desloratadine3Active Not Recruiting1
DB01234Dexamethasone3Active Not Recruiting1
DB01075Diphenhydramine3Active Not Recruiting1
DB14785Fenebrutinib3Active Not Recruiting1
DB00950Fexofenadine3Active Not Recruiting1
DB08868Fingolimod3Completed1
DB08868Fingolimod3Terminated1
DB11526Masitinib3Completed1
DB00959Methylprednisolone3Active Not Recruiting2
DB11988Ocrelizumab3Active Not Recruiting3
DB11988Ocrelizumab3Completed2
DB11988Ocrelizumab3Recruiting2
DB00073Rituximab3Active Not Recruiting1
DB18715Tolebrutinib3Recruiting1
DB06637Dalfampridine4Completed1